An Open-Label, Randomized, Multicenter Study to Evaluate the Additive Effects of Montelukast and/or Salmeterol on Asthma Control Levels in Patients with Poorly Controlled Asthma Treated with Moderate doses of Inhaled Corticosteroid

An Open-Label, Randomized, Multicenter Study to Evaluate the Additive Effects of Montelukast and/or Salmeterol on Asthma Control Levels in Patients with Poorly Controlled Asthma Treated with Moderate doses of Inhaled Corticosteroid - Tokyo Respiratory Eminent Study for Clinical Unmet Effectiveness Study (To Rescue)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000000860

Enrollment

100

Registered

2007-10-22

Start date

2007-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial Asthma

Interventions

Additive and consecutive treatment of Salmeterol and Montelukast Additive and consecutive treatment of Montelukast and Salmeterol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Poorly Controlled Asthma Treated with Moderate doses of Inhaled Corticosteroid

Exclusion criteria

Exclusion criteria: Patients with COPD

Design outcomes

Primary

Measure	Time frame
Asthma control levels	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026